Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03063918 · ClinicalTrials.gov registry record · NA

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

A NA study of Cancer Survivor and Stage I Rectosigmoid Cancer, sponsored by City of Hope Medical Center.

Completed
Registry status
NA
Development phase
10
Enrollment target
2
Study locations

NCT03063918 is a NA study of Cancer Survivor and Stage I Rectosigmoid Cancer that has completed, run by City of Hope Medical Center. The registered enrollment target is 10 participants, below the 266-participant average among 25 other Cancer Survivor trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03063918, a NA study of Cancer Survivor and Stage I Rectosigmoid Cancer, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

This pilot clinical trial studies how well personalized dietary intervention works in managing bowel dysfunction and improving quality of life in stage I-III rectosigmoid cancer survivors. Personalized dietary intervention may help people understand bowel symptoms, identify helpful and troublesome foods for bowel symptoms, adjust diets and food preparation based on food triggers, and coach on healthy diet recommendations after cancer treatment.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Survey Administration
  • OTHER Questionnaire Administration
  • OTHER Informational Intervention
  • BEHAVIORAL Telephone-Based Intervention

Study Locations (2)

Arizona

  • The University of Arizona Medical Center-University Campus - Tucson

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-04-28
Est. Completion 2021-09-07
Phase NA

Sponsor

City of Hope Medical Center

582 total trials

What the Registry Record Tells You About NCT03063918

The ClinicalTrials.gov registry entry for NCT03063918 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 25 other Cancer Survivor trials with a reported enrollment target (96% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cancer Survivor appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.

NCT03063918 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, California.

Frequently Asked Questions

What is clinical trial NCT03063918 about?

NCT03063918 is a clinical study titled "Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors". This pilot clinical trial studies how well personalized dietary intervention works in managing bowel dysfunction and improving quality of life in stage I-III rectosigmoid cancer survivors. Personalized dietary intervention may help people understand bowel symptoms, identify helpful and troublesome f...

What is the current status of trial NCT03063918?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-04-28. Estimated completion is 2021-09-07.

What conditions does trial NCT03063918 study?

This clinical trial studies the following conditions: Cancer Survivor, Stage I Rectosigmoid Cancer, Stage II Rectosigmoid Cancer, Stage III Rectosigmoid Cancer.

What interventions are being tested in trial NCT03063918?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Survey Administration (OTHER), Questionnaire Administration (OTHER), Informational Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03063918?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03063918 being conducted?

This trial has 2 study locations across Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Survivor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.